Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bionano Genomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.139 Good day, and welcome to the Bionano first quarter 2025 earnings conference 00:00:05.139 -- 00:00:07.943 call. Today's conference is being recorded. 00:00:07.943 -- 00:00:11.549 At this time, I would like to turn the conference over to David Holmes from Investor 00:00:11.549 -- 00:00:14.550 Relations. Please go ahead. 00:00:14.934 -- 00:00:17.978 Thank you, Lisa, and good afternoon, everyone. 00:00:17.978 -- 00:00:23.206 Welcome to Bionano first quarter 2025 financial results conference call. 00:00:23.206 -- 00:00:28.314 Leading the call today is Dr. Eric Holman, CEO and Principal Financial Officer of 00:00:28.314 -- 00:00:33.314 Bionano. and he is joined by Mark Adamczyk, Bionano's Vice President of 00:00:33.314 -- 00:00:36.218 Accounting and Principal Accounting Officer. 00:00:36.218 -- 00:00:41.364 After market closed today, Bionano issued a press release accounting 00:00:41.364 -- 00:00:45.088 its financial results for the first quarter 2025. 00:00:45.088 -- 00:00:51.194 A copy of the release can be found on the investor relations page of the company's website. 00:00:52.217 -- 00:00:56.393 Certain statements made during this conference call may be forward-looking statements. 00:00:56.393 -- 00:01:01.562 including statements about BioNano's revenue outlook, profitability, cash 00:01:01.562 -- 00:01:06.750 runway, cost savings initiatives, and commercialization and product plans. 00:01:06.750 -- 00:01:11.959 Such statements are based on current expectations, and there can be no assurances 00:01:11.959 -- 00:01:16.086 that the results contemplated in these statements will be realized. 00:01:16.086 -- 00:01:21.014 Actual results may differ materially from such statements due to several factors and 00:01:21.014 -- 00:01:25.994 risks...